Incyte (INCY) Gross Margin (QoQ) (2012 - 2026)

Incyte (INCY) Gross Margin (QoQ) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Incyte 23.33 Bn 19.32 Bn 1.17 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -17.00
Dec 31, 2025 -79.00
Sep 30, 2025 -77.00
Jun 30, 2025 47.00
Mar 31, 2025 56.00
Dec 31, 2024 5.00
Sep 30, 2024 -22.00
Jun 30, 2024 -42.00
Mar 31, 2024 -4.00
Dec 31, 2023 -34.00
Sep 30, 2023 62.00
Jun 30, 2023 -13.00
Mar 31, 2023 -64.00
Dec 31, 2022 25.00
Sep 30, 2022 -107.00
Jun 30, 2022 26.00
Mar 31, 2022 -73.00
Dec 31, 2021 -18.00
Sep 30, 2021 48.00
Jun 30, 2021 -56.00